Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pim J French

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Journal of Neuro-Oncology|June 27, 2019
Lack of B and T cell reactivity towards IDH1<sup>R132H</sup> in blood and tumor tissue from LGG patientsBas Weenink, Mandy van Brakel, Rebecca Wijers, et al.
Neuro-Oncology Advances|August 22, 2022
The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic reviewKyra X Swildens, Peter A E Sillevis Smitt, Martin J van den Bent, et al.
The Lancet. Oncology|July 10, 2010
Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?Nanne K Kloosterhof, Linda B C Bralten, Hendrikus J Dubbink, et al.
Biomolecules|November 27, 2021
Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug TestingAnnelies Van Hemelryk, Lisanne Mout, Sigrun Erkens-Schulze, et al.
Scientific Reports|October 12, 2019
Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigensBas Weenink, Kaspar Draaisma, Han Z Ooi, et al.
Lancet (London, England)|September 22, 2023
Primary brain tumours in adultsMartin J van den Bent, Marjolein Geurts, Pim J French, et al.
Acta Neuropathologica Communications|December 25, 2015
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patientsKaspar Draaisma, Maarten M J Wijnenga, Bas Weenink, et al.
Iscience|January 2, 2023
Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling dataLevi van Hijfte, Marjolein Geurts, Wies R Vallentgoed, et al.
Neuro-Oncology Advances|February 17, 2025
Transcriptomic analysis of <i>EGFR</i> co-expression and activation in glioblastoma reveals associations with its ligandsSantoesha A Ghisai, Nastaran Barin, Levi van Hijfte, et al.
Molecular Oncology|July 12, 2016
A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumabJosie Hayes, Helene Thygesen, Walter Gregory, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Journal of Neuro-Oncology|June 27, 2019
Lack of B and T cell reactivity towards IDH1<sup>R132H</sup> in blood and tumor tissue from LGG patientsBas Weenink, Mandy van Brakel, Rebecca Wijers, et al.
Neuro-Oncology Advances|August 22, 2022
The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic reviewKyra X Swildens, Peter A E Sillevis Smitt, Martin J van den Bent, et al.
The Lancet. Oncology|July 10, 2010
Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?Nanne K Kloosterhof, Linda B C Bralten, Hendrikus J Dubbink, et al.
Biomolecules|November 27, 2021
Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug TestingAnnelies Van Hemelryk, Lisanne Mout, Sigrun Erkens-Schulze, et al.
Scientific Reports|October 12, 2019
Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigensBas Weenink, Kaspar Draaisma, Han Z Ooi, et al.
Lancet (London, England)|September 22, 2023
Primary brain tumours in adultsMartin J van den Bent, Marjolein Geurts, Pim J French, et al.
Acta Neuropathologica Communications|December 25, 2015
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patientsKaspar Draaisma, Maarten M J Wijnenga, Bas Weenink, et al.
Iscience|January 2, 2023
Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling dataLevi van Hijfte, Marjolein Geurts, Wies R Vallentgoed, et al.
Neuro-Oncology Advances|February 17, 2025
Transcriptomic analysis of <i>EGFR</i> co-expression and activation in glioblastoma reveals associations with its ligandsSantoesha A Ghisai, Nastaran Barin, Levi van Hijfte, et al.
Molecular Oncology|July 12, 2016
A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumabJosie Hayes, Helene Thygesen, Walter Gregory, et al.
Pageof 13